Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
The Neurologist's Experience with Pheochromocytoma
JAMA 197:100, Thomas,J.E.,et al, 1966
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
C-Reactive Protein Level Measurement Improves Mortality Prediction When Added to the Spontaneous Intracerebral Hemorrhage Score
Stroke 42:1230-1236, Napoli, M.D.,et al, 2011
Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004
The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Prognostic Factors in Patients with Intracerebral Haematoma
JNNP 55:653-657, Franke,C.L.,et al, 1992
Deteriorating Ischemic Stroke:Risk Factors and Prognosis
Neurol 40:1865-1869, Davalos,A.,et al, 1990
Admission Glucose Level in Relation to Mortality Outcome in 252 Stroke Patients
Stroke 19:185-191, Woo,E.,et al, 1988
Blood Glucose and Stroke
Stroke 19:1049-1053, Helgason,C.M., 1988